Unknown

Dataset Information

0

Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia.


ABSTRACT: An increasing numbers of patients are being diagnosed with asymptomatic early-stage chronic lymphocytic leukemia (CLL), with no treatment indication at baseline. We applied a high-throughput deep-targeted analysis, especially designed for covering widely TP53 and ATM genes, in 180 patients with inactive disease at diagnosis, to test the independent prognostic value of CLL somatic recurrent mutations. We found that 40/180 patients harbored at least one acquired variant with ATM (n=17, 9.4%), NOTCH1 (n=14, 7.7%), TP53 (n=14, 7.7%) and SF3B1 (n=10, 5.5%) as most prevalent mutated genes. Harboring one 'sub-Sanger' TP53 mutation granted an independent 3.5-fold increase of probability of needing treatment. Those patients with a double-hit ATM lesion (mutation+11q deletion) had the shorter median time to first treatment (17 months). We found that a genomic variable: TP53 mutations, most of them under the sensitivity of conventional techniques; a cell phenotypic factor: CD38-positive expression; and a classical marker as ?2-microglobulin, remained as the unique independent predictors of outcome. The high-throughput determination of TP53 status, particularly in this set of patients frequently lacking high-risk chromosomal aberrations, emerges as a key step, not only for prediction modeling, but also for exploring mutation-specific therapeutic approaches and minimal residual disease monitoring.

SUBMITTER: Hurtado AM 

PROVIDER: S-EPMC4558590 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia.

Hurtado A M AM   Chen-Liang T-H TH   Przychodzen B B   Hamedi C C   Muñoz-Ballester J J   Dienes B B   García-Malo M D MD   Antón A I AI   de Arriba F F   Teruel-Montoya R R   Ortuño F J FJ   Vicente V V   Maciejewski J P JP   Jerez A A  

Blood cancer journal 20150828


An increasing numbers of patients are being diagnosed with asymptomatic early-stage chronic lymphocytic leukemia (CLL), with no treatment indication at baseline. We applied a high-throughput deep-targeted analysis, especially designed for covering widely TP53 and ATM genes, in 180 patients with inactive disease at diagnosis, to test the independent prognostic value of CLL somatic recurrent mutations. We found that 40/180 patients harbored at least one acquired variant with ATM (n=17, 9.4%), NOTC  ...[more]

Similar Datasets

| S-EPMC3924925 | biostudies-literature
| S-EPMC4392212 | biostudies-other
| S-EPMC4140768 | biostudies-literature
| S-EPMC2773482 | biostudies-literature
| S-EPMC5802577 | biostudies-literature
| S-EPMC4017291 | biostudies-literature
| S-EPMC3700393 | biostudies-literature
| S-EPMC3549718 | biostudies-literature
| S-EPMC3207001 | biostudies-literature
| S-EPMC6010869 | biostudies-other